A Study of DCC-2701 in Participants With Advanced Solid Tumors
Status:
Terminated
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to investigate the safety of the investigational drug
DCC-2701 and whether it will work to help people who have advanced solid tumors or cancer
that has spread to other parts of the body.